BCM
ABBV icon

Brainard Capital Management’s AbbVie ABBV Stock Holding History

Brainard Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$435K Buy
2,725
+8
+0.3% +$1.22K 0.33% 47
2022
Q4 		$439K Buy
+2,717
New +$417K 0.37% 45

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Brainard Capital Management's ABBV Position: Q1 2023 in Review

Brainard Capital Management increased its AbbVie (ABBV) stake by 0.29% in Q1 2023, buying an estimated $1.22K and bringing the position to 2,725 shares worth $435K. The position accounts for 0.33% of the portfolio, ranked #47.

Brainard Capital Management first reported a position in ABBV in Q4 2022 and has held it in 2 quarters since. The position peaked at $439K in Q4 2022. 3,141 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Brainard Capital Management held 2,725 shares of AbbVie worth $435K as of Q1 2023.
  • Brainard Capital Management bought 8 AbbVie shares in Q1 2023, an estimated $1.22K.
  • AbbVie made up 0.33% of Brainard Capital Management's portfolio in Q1 2023, its #47 holding.
  • Brainard Capital Management first reported a position in AbbVie in Q4 2022 and has held it in 2 quarters since.
  • Brainard Capital Management's AbbVie position peaked at $439K in Q4 2022.
  • 3,141 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Brainard Capital Management's 13F filing for Q1 2023, filed 9 May 2023.